Long-term efficacy and safety of larotrectinib in an integrated dataset of patients with TRK fusion cancer.

被引：23

作者：

Hong, David S.

Shen, Lin

van Tilburg, Cornelis Martinus

Tan, Daniel Shao-Weng

Kummar, Shivaani

Lin, Jessica Jiyeong

Doz, Francois P.

McDermott, Raymond S.

Albert, Catherine M.

Berlin, Jordan

Bielack, Stefan S.

Lassen, Ulrik Niels

Tahara, Makoto

Norenberg, Ricarda

Shurshalina, Anna

Fellous, Marc Mardoche

Nogai, Hendrik

Xu, Rui-hua

Laetsch, Theodore Willis

Drilon, Alexander E.

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol, Beijing, Peoples R China

[3] Heidelberg Univ Hosp, Hopp Childrens Canc Ctr Heidelberg KiTZ, Heidelberg, Germany

[4] German Canc Res Ctr, Heidelberg, Germany

[5] Natl Canc Ctr Singapore, Singapore, Singapore

[6] OHSU, Knight Canc Inst, Portland, OR USA

[7] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA

[8] Harvard Med Sch, Boston, MA 02115 USA

[9] Inst Curie, Paris, France

[10] Univ Paris, Paris, France

[11] St Vincents Univ Hosp, Dublin, Ireland

[12] Canc Trials Ireland, Dublin, Ireland

[13] Seattle Childrens Hosp, Seattle, WA USA

[14] Univ Washington, Sch Med, Seattle, WA USA

[15] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[16] Klinikum Stuttgart Olgahosp, Stuttgart, Germany

[17] Rigshosp, Dept Oncol, Copenhagen, Denmark

[18] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[19] Chrestos Concept GmbH & Co KG, Essen, Germany

[20] Bayer HealthCare Pharmaceut Inc, Whippany, NJ USA

[21] Bayer HealthCare Pharmaceut Inc, Basel, Switzerland

[22] Bayer AG, Wuppertal, Germany

[23] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Peoples R China

[24] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA

[25] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[26] Weill Cornell Med Coll, New York, NY USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.3108

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3108

引用

页数：2

共 50 条

[21] Long-term efficacy and safety of larotrectinib (laro) in patients (pts) with TRK fusion thyroid carcinoma (TC)
Cabanillas, Maria E.
Lin, Jessica Jiyeong
Brose, Marcia S.
McDermott, Raymond S.
Almubarak, Mohammed
Bauman, Jessica R.
Casanova, Michela
Kummar, Shivaani
Lee, Se-Hoon
Leyvraz, Serge
Oh, Do-Youn
Shen, Lin
Neu, Natascha
Bernard-Gauthier, Vadim
Mussi, Chiara E.
Hong, David S.
Drilon, Alexander E.
Waguespack, Steven G.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[22] Long-term outcomes of patients with TRK fusion cancer treated with larotrectinib.
Drilon, Alexander
Kummar, Shivaani
Albert, Catherine M.
Nagasubramanian, Ramamoorthy
Hechtman, Jaclyn F.
Reeves, John A.
Beckmann, Georg
Rudolph, Marion
Wierzbinska, Justyna A.
Dima, Laura
Brega, Nicoletta
Laetsch, Theodore W.
Hong, David S.
CANCER RESEARCH, 2021, 81 (13)
[23] Updated efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer.
Drilon, Alexander E.
Lin, Jessica Jiyeong
Kummar, Shivaani
Tan, Daniel Shao-Weng
Patel, Jyoti D.
Lassen, Ulrik Niels
Leyvraz, Serge
Moreno, Victor
Rosen, Lee S.
Solomon, Benjamin Maurice
Yachnin, Jeffrey
Liu, Yongmei
Dai, Ming-Shen
Norenberg, Ricarda
Fellous, Marc Mardoche
Mussi, Chiara Erminia
Shen, Lin
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[24] Updated efficacy and safety of larotrectinib (laro) in patients (pts) with TRK fusion gastrointestinal (GI) cancer.
Shen, Lin
Andre, Thierry
Chung, Hyun Cheol Cheol
Deeken, John F.
Garralda, Elena
Italiano, Antoine
Leyvraz, Serge
Liu, Tianshu
Burcoveanu, Domnita-Ileana
Grugel, Robin
Mussi, Chiara E.
Xu, Rui-Hua
Hong, David S.
Drilon, Alexander E.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 109 - 109
[25] Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion gastrointestinal (GI) cancer: An updated analysis
Andre, T.
Hong, D.
Deeken, J.
Italiano, A.
Liu, T.
Burcoveanu, D.
Norenberg, R.
Mussi, C.
Xu, R.
Drilon, A.
Shen, L.
ANNALS OF ONCOLOGY, 2023, 34 : S12 - S13
[26] LONG-TERM FOLLOW-UP OF THE EFFICACY AND SAFETY OF LAROTRECTINIB IN PAEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER
Federman, Noah
Van Tilburg, Cornelis
Dierselhuis, Miranda
Albert, Catherine
Geoerger, Birgit
Dubois, Steven
Mascarenhas, Leo
Nagasubramanian, Ramamoorthy
Pappo, Alberto
Watt, Tanya
Bernard-Gauthier, Vadim
Norenberg, Ricarda
De la Cuesta, Esther
Doz, Francois
Zhang, Yizhuo
PEDIATRIC BLOOD & CANCER, 2023, 70
[27] Larotrectinib efficacy and safety in adult TRK fusion cancer patients.
Hong, David S.
Kummar, Shivaani
Farago, Anna F.
Lassen, Ulrik Niels
Berlin, Jordan
Schilder, Russell J.
McDermott, Raymond S.
Patel, Jyoti D.
Dowlati, Afshin
Doebele, Robert Charles
Tan, Daniel Shao-Weng
Lee, James J.
Nanda, Shivani
Childs, Barrett H.
Ku, Nora
Drilon, Alexander E.
Hyman, David Michael
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[28] Larotrectinib efficacy and safety in pediatric TRK fusion cancer patients.
van Tilburg, Cornelis Martinus
DuBois, Steven G.
Albert, Catherine Michelle
Federman, Noah
Nagasubramanian, Ramamoorthy
Geoerger, Birgit
Orbach, Daniel
Bielack, Stefan S.
Shukla, Neerav Narendra
Turpin, Brian
Casanova, Michela
Spunt, Sheri L.
Qamoos, Hope
Nanda, Shivani
Childs, Barrett H.
Cox, Michael Craig
Pappo, Alberto S.
Laetsch, Theodore Willis
Mascarenhas, Leo
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[29] Long-term efficacy and safety of larotrectinib in non-primary central nervous system (CNS) TRK fusion cancer
Drilon, A. E.
Xu, R-H.
van Tilburg, C. M.
Doz, F.
Tan, D. S. W.
Lin, J. J.
Geoerger, B.
Zwaan, C. M.
Lassen, U. N.
Italiano, A.
Kummar, S.
McDermott, R. S.
Burcoveanu, D-I.
Neu, N.
Brega, N.
Laetsch, T.
Hong, D. S.
Shen, L.
ANNALS OF ONCOLOGY, 2024, 35 : S500 - S501
[30] Larotrectinib (laro) long-term efficacy and safety in patients (pts) with tropomyosin receptor kinase (TRK) fusion thyroid carcinoma (TC)
Cabanillas, Maria E.
Lin, Jessica Jiyeong
Brose, Marcia S.
McDermott, Raymond S.
Almubarak, Mohammed
Bauman, Jessica R.
Casanova, Michela
Kummar, Shivaani
Lee, Se-Hoon
Leyvraz, Serge
Oh, Do-Youn
Shen, Lin
Norenberg, Ricarda
Bernard-Gauthier, Vadim
Mussi, Chiara E.
Hong, David S.
Drilon, Alexander E.
Waguespack, Steven G.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)

← 1 2 3 4 5 →